Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Florida Marijuana Info.Org Has Exclusive Interview with Trulieve, Florida’s First Medical Cannabis Dispensary
  • USA - English


News provided by

Florida Marijuana Info.Org

Aug 15, 2016, 03:00 ET

Share this article

Share toX

Share this article

Share toX


Florida (PRWEB) August 15, 2016 -- You wouldn’t think that a clean, new strip mall in little ole Tallahassee, Florida, holds one of the biggest advancements in medicine in decades. On Tuesday July 26, Trulieve, the first medical cannabis dispensary in the state, opened doors to its first sale of legal cannabis product to wheelchair-bound Dallas Nagy -- to much clapping and cheering from the crowd that had squeezed into the small front of the shop for this historic moment.

With one newly opened location, Trulieve has plans to open up locations in Clearwater, Tampa, St. Petersburg, Pensacola and Bradenton by the end of the year.

Post this

Trulieve Dispensary holds one of six licenses in Florida which allows nursery operations to grow medical cannabis. Having slogged through a 2,000 page application, CEO Kim Rivers noted that it was a “long road, two years” to get to this point of distributing medicine.

Partnered with Hackney Nursery, located in Quincey, just north of Tallahassee, Trulieve offers high-CBD, low-THC products. THC is the cannabis chemical that gives a patient a euphoric “high”. That particular product won’t be available until August and it’s required that the ill patient have two recommendations from physicians of his or her terminally ill status. CBD, in the meantime, is thought to have anti-seizure and anti-spasmodic qualities, along with a laundry list of other anecdotal uses.

At Trulieve, high CBD products come in two types: oral and that which you inhale. The oral medications come in capsules, as a tincture in a bottle or in an oral syringe. The inhalation method uses vaporizers with either the vape that uses a pen-like cartridge filled with cannabis oil. The other vaporizer is for use with cannabis flowers because Trulieve recognizes that there are some people who are traditionalists who like to inhale their medication.

In the meantime, patients like Nagy, who lives about two hours out of Tallahassee in Hudson, Florida, gains access to high-CBD products which he uses to control seizures and muscle spasms. And according to COO Jason Parnell, the medicine Trulieve offers is lab certified as free from pesticides, insecticides and other undesirable chemicals. The secret: Inside growing.

“We control the entire environment of that plant,” Parnell said. “This medicine is going to patients with already compromised immune systems. So we offer the highest quality product possible without having to worry about Mother Nature [as compared with outside grow operations].”

Medical director Dr. Ken Brummel-Smith observed that the Quincy grow house is technologically advanced. “Really, it’s like walking into NASA. It’s just unbelievable what they have done to create this incredibly safe environment to grow the plants – not only in the most efficient way, but in the safest way,” Brummel-Smith said.

Trulieve has its own on-site laboratory with a full-time lab director. The company regularly tests its medicines on a regular basis by its own lab and by an independent outside lab.

But growing high-CBD plants seems to be the least of this new industry’s problem. Florida physicians are required to take an eight-hour course on the use of medical marijuana, then an exam. They are then to register with the newly created state Office of Compassionate Use. Though about a hundred or so doctors have taken the course and exam, only about ten percent are registered and able to recommend medical cannabis to patients.

“Patients should encourage their physicians to take the course to get certified but many won’t,” said Brummel-Smith. “Many doctors are worried that marijuana is still illegal from a federal standpoint. But the federal government defunded enforcement efforts against doctors prescribing medical cannabis. So, to me, the general risk is none.”

Cannamoms.com co-founder Moriah Barnhart reiterated this point. “We are begging the doctors of Florida to become certified to be able to order medicine for patients,” she said. “What you’re going to find is a lot of people searching for help and not enough medical professionals to help patients.”

One sticking point of the 2014 enabling legislation is the stipulation that the patient and doctor have a 90-day established relationship before any recommendations for cannabis meds can be given. This, say critics, is a requirement that is burdensome, and possibly expensive, for the patient. And though a patient may be chronically ill, they would still need a working relationship with a certified physician. And wait three months, at least.

Critics of the law also say that the categories of chronic illnesses could, and should, be expanded so that more patients qualify for medical marijuana. Said Dr. Brummel-Smith about Amendment 2, an upcoming referendum question that would increase the number of illnesses that would qualify for medical cannabis, “In general, expanding the options [of treatable conditions] is important.”

Presently, only those patients who suffer from pain, nausea, loss of appetite due to cancer or who experience seizures and severe and chronic muscle spasms qualify to use medical cannabis.

With one newly opened location, Trulieve has plans to open up locations in Clearwater, Tampa, St. Petersburg, Pensacola and Bradenton by the end of the year. So for the lucky few who live in central Florida and who qualify for medical cannabis and can locate a certified physician, there’s a medical marijuana dispensary coming near you. To stay up-to-date on all things marijuana in the state of Florida, click to our website at http://www.floridamarijuanainfo.org.

For more information about the exclusive interview with Trulieve and Florida Marijuana Info, contact us at 855-901-8800.

Marketing Department, Florida Marijuana Info.Org, http://www.floridamarijuanainfo.org, +1 561-271-7611, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.